Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Mixed Q4; Encouraging Update from GS7977 Program in HCV

Go back to Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD); Mixed Q4; Encouraging Update from GS7977 Program in HCV
Gilead Sciences (NASDAQ: GILD) Delayed: 138.92 +0.56 (0.40%)
Previous Close $138.36    52 Week High $108.63 
Open $138.36    52 Week Low $71.39 
Day High $138.95    P/E 76.75 
Day Low $136.63    EPS $1.81 
Volume 619,410